Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Lumos Diagnostics and RPS Diagnostics announced they have merged. The combined company will be called Lumos Diagnostics.
read more
Luminex announced the company submitted the ARIES® MRSA Assay to the U.S. Food and Drug Administration (FDA) for clearance.
read more
Luminer has streamlined its product inspection capabilities by introducing a dedicated 7,000-square-foot inspection suite at its primary manufacturing facility in Lakewood, NJ.
read more
Monday, November 25, 2019
Luminer has completed an expansion of its primary manufacturing facility in Lakewood, NJ.
read more
Luminer has incorporated a new state-of-the-art ECL production line at its primary manufacturing facility in Lakewood, NJ.
read more
Lumicera Health Services announced the launch of Clarventa, a new company created to address one of the most persistent drivers of rising prescription drug costs: the complex pharmaceutical supply chain.
read more
Lumanity announced the acquisition of Endpoint Outcomes, a company specializing in harnessing the voice of patients to document the impact of treatments on health-related quality of life.
read more
Monday, November 05, 2018
The Lubrizol Corporation announces it will invest more than $25 million in its Calvert City, Kentucky manufacturing facility.
read more
Friday, November 14, 2014
The Lubrizol Corporation’s LifeSciences business, a
leading supplier of advanced materials for the pharmaceutical and medical device
industry, will showcase its extensive range of material solutions for the pharmaceutical
industry at the ...
read more
Friday, November 14, 2014
The Lubrizol Corporation announces an alliance between Lubrizol LifeSciences, a leading supplier of advanced materials for the healthcare industry, and
Particle Sciences, an integrated provider of drug development services.
read more
Lubrizol announces the acquisition of Bavaria Medizin Technologie GmbH, a designer and manufacturer of both intravascular and nonvascular devices, by its German subsidiary Lubrizol Deutschland GmbH.
read more
Wednesday, April 29, 2026
LTS LOHMANN Therapie-Systeme AG announced the expansion of its service portfolio to include CDMO services for ophthalmic drug delivery solutions, with manufacturing capacities located in the United States at LTS' Lakewood, New Jersey facility.
read more
Wednesday, October 15, 2025
LTS LOHMANN Therapie-Systeme AG announced the acquisition of Renaissance Lakewood, a US-based contract development and manufacturing organization (CDMO) specializing in nasal sprays and sterile dosage forms.
read more
Thursday, September 30, 2021
Larsen & Toubro Infotech a global technology consulting and digital solutions company has entered in a strategic partnership with eClinicalHealth Limited to accelerate digital innovation in R&D Clinical Trials Management process for patient-centric ...
read more
LSPedia has been awarded a contract by the U.S. Department of Veterans Affairs to provide cutting-edge solutions ensuring compliance with the FDA's Drug Supply Chain Security Act (DSCSA). Enacted in 2013, the DSCSA mandates end-to-end traceability ...
read more